Adhera Therapeutics Appoints Nancy Phelan as Chief Executive Officer
April 04, 2019 09:15 ET
|
Adhera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, NC, April 04, 2019 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and...
Adhera Therapeutics Provides Third Quarter 2018 Financial Results and Business Update
November 20, 2018 19:08 ET
|
Adhera Therapeutics, Inc.
Research Triangle Park, NC, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), an emerging specialty pharmaceutical company commercializing therapies that leverage its...
Marina Biotech Announces Name Change to Adhera Therapeutics to More Closely Reflect the Mission of Improving Patient Outcomes
October 09, 2018 08:00 ET
|
Marina Biotech, Inc.
Research Triangle Park, NC, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of...
Marina Biotech Appoints Eric Teague as Chief Financial Officer
September 24, 2018 08:00 ET
|
Marina Biotech, Inc.
Research Triangle Park, NC, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of...
Marina Biotech Appoints Robert Moscato to Chief Executive Officer
June 20, 2018 11:30 ET
|
Marina Biotech, Inc.
City of Industry, CA, June 20, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of innovative...
Marina Biotech Announces a New Publication on Prestalia®
February 27, 2018 10:15 ET
|
Marina Biotech, Inc.
City of Industry, CA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
Marina Biotech Announces Agreement for Drug Development and Licensing with Autotelic Bio
January 16, 2018 08:40 ET
|
Marina Biotech, Inc.
City of Industry, CA, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
Marina Biotech Appoints Isaac Blech to its Board of Directors
November 27, 2017 08:30 ET
|
Marina Biotech, Inc.
City of Industry, CA , Nov. 27, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
Marina Biotech Appoints Chief Legal Officer to Support Legal, Transactional and Intellectual Property Portfolio Initiatives
October 19, 2017 08:30 ET
|
Marina Biotech, Inc.
City of Industry, CA, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
Marina Biotech Appoints Amit Shah as Chief Financial Officer
October 05, 2017 08:30 ET
|
Marina Biotech, Inc.
City of Industry, CA, Oct. 05, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...